RRFDX
Price
$36.98
Change
-$0.42 (-1.12%)
Updated
Oct 16 closing price
Net Assets
16.23B
VIVIX
Price
$72.05
Change
-$0.72 (-0.99%)
Updated
Oct 16 closing price
Net Assets
207.8B
Interact to see
Advertisement

RRFDX vs VIVIX

Header iconRRFDX vs VIVIX Comparison
Open Charts RRFDX vs VIVIXBanner chart's image
T. Rowe Price Equity Income R
Price$36.98
Change-$0.42 (-1.12%)
VolumeN/A
Net Assets16.23B
Vanguard Value Index I
Price$72.05
Change-$0.72 (-0.99%)
VolumeN/A
Net Assets207.8B
RRFDX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
RRFDX vs. VIVIX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RRFDX is a Hold and VIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 208B vs. RRFDX (16.2B). VIVIX pays higher dividends than RRFDX: VIVIX (2.09) vs RRFDX (1.19). RRFDX was incepted earlier than VIVIX: RRFDX (23 years) vs VIVIX (27 years). RRFDX (1.25) is less costly to investors than VIVIX (0.04). RRFDX is a more actively managed with annual turnover of: 21.40 vs. VIVIX (9.00). RRFDX has a lower initial minimum investment than VIVIX: RRFDX (2500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 5.03 vs. RRFDX (-1.65). VIVIX return over 5 years is better than : 72.63 vs. RRFDX (45.69).
RRFDXVIVIXRRFDX / VIVIX
Total Expense Ratio1.250.043,125%
Annual Report Gross Expense Ratio1.250.043,125%
Fund Existence23 years27 years-
Gain YTD9.65110.29394%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets16.2B208B8%
Annual Yield % from dividends1.192.0957%
Returns for 1 year-1.655.03-33%
Returns for 3 years24.7445.5654%
Returns for 5 years45.6972.6363%
Returns for 10 years39.71130.4630%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN23.010.74
+3.32%
Viridian Therapeutics
NHPAP17.84-0.14
-0.78%
National Healthcare Properties Inc
CCRN12.85-0.20
-1.53%
Cross Country Healthcare
BZ21.50-0.50
-2.27%
Kanzhun Limited
LICN4.35-0.22
-4.81%
Lichen International Limited